24 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native Hawaiian or Pacific
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
Sensitivity of the input to fair value
Warrant liability related to the private placement warrants
Black- Scholes model
Expected volatility
2023: n/a
2022 … :
December 31,
Expected volatility (%)
Risk-free interest rate (%)
Expected life of warrants (years)
Market price of ADS ($)
Model used
Black-Scholes
13
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
(or purchase) Company shares without the restrictions of trading windows and black-out periods, even when there is undisclosed material information … about the Company, and only during a trading window period outside of the trading black-out period, and the person who entered into the Trading Plan
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
7 Sep 23
Current report (foreign)
7:37am
June 30, 2023, were valued using the Black-Scholes model with the following weighted average inputs: expected volatility of
98.06%; risk free … the six months ended June 30, 2023 were valued using the Black-Scholes model with the following inputs: expected volatility of
97.94%; risk free
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
2 Nov 22
Current report (foreign)
4:17pm
.
The weighted average exercise price is $1.24 per ADS.
Options over ADSs issued during the six months ended June 30, 2022 were valued using the Black … )
Market price of ADS($)
Model used
Black-Scholes
Volatility was estimated by reference to the one year historical volatility of the historical share price
6-K
EX-99.1
04mzdc6s
2 Nov 21
Current report (foreign)
4:16pm
6-K
EX-99.2
p1sc74x3g
29 Sep 20
Current report (foreign)
7:08am
6-K
24eozn8
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-10.1
wpeuby
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
6-K
EX-10.4
gs1jbvc83w
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
1n3c eclnv
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
r8fnhw3m19 lft9v
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
c1w75rw6rnnetmk7ob8
17 Sep 19
Current report (foreign)
8:06am
20-F
zwwelse0
29 Apr 19
Annual report (foreign)
4:59pm
6-K
zhdi6h5ory3frf7i5
29 Apr 19
Current report (foreign)
12:09pm
425
cbz8 yx1e
12 Mar 19
Business combination disclosure
9:27am
425
5uqjnbai 2plf0eenl63
15 Feb 19
Business combination disclosure
6:50am